Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies
Introduction Pathological confidence in one’s thoughts is a key mechanism of chronic paranoid thinking. For this reason, many of the current therapies focus on trying to reduce it. In fact, the way some antipsychotics (e.g., haloperidol) work seems to be through the induction of doubt. Because of th...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Psychology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fpsyg.2019.02099/full |
_version_ | 1811274113440808960 |
---|---|
author | Leonor Asensio-Aguerri Luis Beato-Fernández Luis Beato-Fernández Maria Stavraki Teresa Rodríguez-Cano Teresa Rodríguez-Cano Miriam Bajo Darío Díaz |
author_facet | Leonor Asensio-Aguerri Luis Beato-Fernández Luis Beato-Fernández Maria Stavraki Teresa Rodríguez-Cano Teresa Rodríguez-Cano Miriam Bajo Darío Díaz |
author_sort | Leonor Asensio-Aguerri |
collection | DOAJ |
description | Introduction Pathological confidence in one’s thoughts is a key mechanism of chronic paranoid thinking. For this reason, many of the current therapies focus on trying to reduce it. In fact, the way some antipsychotics (e.g., haloperidol) work seems to be through the induction of doubt. Because of the impact of these pathological thoughts on positive health, studying the well-being of people who experience paranoid thoughts is fundamental. The first objective of this research is to apply the Complete State Model of Health (CSMH) to a sample of patients characterized by the presence of paranoid thinking. Our second objective is to evaluate the impact of therapies based on reducing pathological confidence on patients’ well-being.MethodsSixty participants with SCID-5 confirmed DSM-5 diagnosis related with paranoid thinking and without mood symptoms were recruited. In order to test the existence of a two continua model of mental health (CSMH), we conducted a parallel analysis and an exploratory factor analysis. To test our hypothesis regarding the partially mediating role of doubt between paranoid thinking and patients’ well-being, we conducted a biased corrected bootstrapping procedure.ResultsAs expected, two different unipolar dimensions emerged from the measures used to assess paranoid thinking and positive health (two continua model of mental health). When patients received metacognitive and pharmacological treatment, more paranoid thinking led to more doubt in all thoughts, which in turn affected well-being. The analyses carried out confirmed the partial mediating role of doubt.ConclusionDespite the efficacy shown by both metacognitive therapies and antipsychotics, it seems that they not only reduce pathological confidence, but can also affect other thoughts not linked to delirium. This effect of generalization of doubt in all thoughts negatively affected patients’ well-being and quality of life. |
first_indexed | 2024-04-12T23:13:14Z |
format | Article |
id | doaj.art-c406c34ee3bf47cbab622dc2d9c14ede |
institution | Directory Open Access Journal |
issn | 1664-1078 |
language | English |
last_indexed | 2024-04-12T23:13:14Z |
publishDate | 2019-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Psychology |
spelling | doaj.art-c406c34ee3bf47cbab622dc2d9c14ede2022-12-22T03:12:45ZengFrontiers Media S.A.Frontiers in Psychology1664-10782019-09-011010.3389/fpsyg.2019.02099464977Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive TherapiesLeonor Asensio-Aguerri0Luis Beato-Fernández1Luis Beato-Fernández2Maria Stavraki3Teresa Rodríguez-Cano4Teresa Rodríguez-Cano5Miriam Bajo6Darío Díaz7Mental Health Unit, Hospital General Universitario de Ciudad Real, Ciudad Real, SpainMental Health Unit, Hospital General Universitario de Ciudad Real, Ciudad Real, SpainCiudad Real Medical School, Universidad de Castilla – La Mancha, Ciudad Real, SpainCiudad Real Medical School, Universidad de Castilla – La Mancha, Ciudad Real, SpainMental Health Unit, Hospital General Universitario de Ciudad Real, Ciudad Real, SpainCiudad Real Medical School, Universidad de Castilla – La Mancha, Ciudad Real, SpainCiudad Real Medical School, Universidad de Castilla – La Mancha, Ciudad Real, SpainCiudad Real Medical School, Universidad de Castilla – La Mancha, Ciudad Real, SpainIntroduction Pathological confidence in one’s thoughts is a key mechanism of chronic paranoid thinking. For this reason, many of the current therapies focus on trying to reduce it. In fact, the way some antipsychotics (e.g., haloperidol) work seems to be through the induction of doubt. Because of the impact of these pathological thoughts on positive health, studying the well-being of people who experience paranoid thoughts is fundamental. The first objective of this research is to apply the Complete State Model of Health (CSMH) to a sample of patients characterized by the presence of paranoid thinking. Our second objective is to evaluate the impact of therapies based on reducing pathological confidence on patients’ well-being.MethodsSixty participants with SCID-5 confirmed DSM-5 diagnosis related with paranoid thinking and without mood symptoms were recruited. In order to test the existence of a two continua model of mental health (CSMH), we conducted a parallel analysis and an exploratory factor analysis. To test our hypothesis regarding the partially mediating role of doubt between paranoid thinking and patients’ well-being, we conducted a biased corrected bootstrapping procedure.ResultsAs expected, two different unipolar dimensions emerged from the measures used to assess paranoid thinking and positive health (two continua model of mental health). When patients received metacognitive and pharmacological treatment, more paranoid thinking led to more doubt in all thoughts, which in turn affected well-being. The analyses carried out confirmed the partial mediating role of doubt.ConclusionDespite the efficacy shown by both metacognitive therapies and antipsychotics, it seems that they not only reduce pathological confidence, but can also affect other thoughts not linked to delirium. This effect of generalization of doubt in all thoughts negatively affected patients’ well-being and quality of life.https://www.frontiersin.org/article/10.3389/fpsyg.2019.02099/fullwell-beingquality of lifeparanoid thinkingdoubtComplete State Model of Health |
spellingShingle | Leonor Asensio-Aguerri Luis Beato-Fernández Luis Beato-Fernández Maria Stavraki Teresa Rodríguez-Cano Teresa Rodríguez-Cano Miriam Bajo Darío Díaz Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies Frontiers in Psychology well-being quality of life paranoid thinking doubt Complete State Model of Health |
title | Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies |
title_full | Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies |
title_fullStr | Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies |
title_full_unstemmed | Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies |
title_short | Paranoid Thinking and Wellbeing. The Role of Doubt in Pharmacological and Metacognitive Therapies |
title_sort | paranoid thinking and wellbeing the role of doubt in pharmacological and metacognitive therapies |
topic | well-being quality of life paranoid thinking doubt Complete State Model of Health |
url | https://www.frontiersin.org/article/10.3389/fpsyg.2019.02099/full |
work_keys_str_mv | AT leonorasensioaguerri paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies AT luisbeatofernandez paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies AT luisbeatofernandez paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies AT mariastavraki paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies AT teresarodriguezcano paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies AT teresarodriguezcano paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies AT miriambajo paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies AT dariodiaz paranoidthinkingandwellbeingtheroleofdoubtinpharmacologicalandmetacognitivetherapies |